BioSpace News Archive

A new nonsurgical treatment decreases errant blood flow in the shoulder to quickly reduce pain and improve function in patients with adhesive capsulitis, also known as “frozen shoulder,” according to research presented during a virtual session of the Society of Interventional Radiology’s 2020 Annual Scientific Meeting on June 13.

Data from one of the first clinical uses of augmented reality guidance with electromagnetically tracked tools shows that the technology can help doctors quickly, safely, and accurately deliver targeted liver cancer treatments, according to research presented during a virtual session of the Society of Interventional Radiology’s 2020 Annual Scientific Meeting on June 14.

While medication non-adherence in clinical trials has been widely recognized as a challenge in drug development1, reported non-adherence rates have been largely anecdotal, isolated to individual studies, and varied widely in their estimations

This first clinical trial of TP-03 for Demodex Blepharitis showed rapid, complete, and durable efficacy with no serious adverse effects.

HandsFree Health™, provider of WellBe®, a secure, HIPAA compliant, voice-enabled virtual health assistant platform, announces Co-Founder Dan Messina will speak at Wednesday’s VOICE Global Summit, a 24-hour livestream conference featuring voice technology leaders.

As robots gain attention as weapons to fight the spread of Coronavirus globally, Blue Ocean Robotics announced that it has been included in Robotics Business Review’s list of the 50 most influential robotics companies in the world (RBR50) for its UVD Robots

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases, today announced it has completed enrollment in the Phase II PEGASUS trial assessing AMX0035 in individuals with Alzheimer’s disease. Amylyx completed

Through the ADA’s first ever endorsement of a dental benefits technology company - Bento, a modern alternative to traditional dental insurance, looks to provide access to affordable oral care nationwide.

Kalderos, creator of the country’s first and only drug discount management solution, announced today that it has secured $28 million in Series B funding to expand its capabilities to solidify its point-of-sale solution, expand to directly support patient and other discount types,

Study by CHOP researchers has implications for those seeking to understand the drivers of asthma exacerbations